Posted on April 16th, 2012, 9:59 am
NASDAQ "The Endurant Stent Graft is performing just as well at two years as it did at one year, with no aneurysm-related mortalities, migrations or conversions," said the study's principal investigator, Michel Makaroun, professor and chief of vascular surgery ... |